Menu
Recruiting NCT07243652

I-DECIDE After Bronchiolitis Hospitalization

No phase Interventional Bronchiolitis Acute

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Moderate-Resource Implementation Strategy, High-Resource Implementation Strategy.
Who it may be relevant to
Registry conditions: Bronchiolitis Acute. Basic parameters: 0 months — 24 months · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Cluster Randomized Trial of a Moderate vs High Resource Implementation Strategy to Increase As-needed Post-hospitalization Follow-up for Children With Bronchiolitis

Overview

Although automatic follow-up is a nearly universal practice, research has shown that these visits are often unnecessary after hospitalizations caused by bronchiolitis. Despite endorsement by national pediatric authorities, robust evidence, and family enthusiasm for as-needed (PRN) follow-up, it remains substantially underutilized for children hospitalized for bronchiolitis. The goal of I-DECIDE is to compare the effects of two multi-component implementation strategies, both of which aim to (a) increase PRN follow-up prescribing by hospitalists (physicians who care for hospitalized children) and (b) decrease unnecessary follow-up visit attendance by families.

Interventions

  • Other Moderate-Resource Implementation Strategy
    The moderate-resource implementation strategy includes educational outreach (including family-facing materials to support follow-up decision making), audit and feedback (review of clinician performance, captured in a structured report), and materials for clinical decision support.
  • Other High-Resource Implementation Strategy
    The high-resource implementation strategy includes all of the moderate resource components, plus two forms of external facilitation: small-group facilitation and expert clinical decision support coach-led facilitation. In total, the high-resource implementation strategy includes educational outreach (including family-facing materials to support follow-up decision-making), audit and feedback (review of clinician performance, captured in a structured report), materials for clinical decision suppor

Primary outcome measures

  • Adoption [Time frame: Within 7 days of hospital discharge]
Secondary outcome measures (1)
  • Sustainment [Time frame: Within 7 days of hospital discharge]

Eligibility criteria

Inclusion criteria

  • Primary diagnosis of bronchiolitis, discharged by a generalist inpatient service from a non-ICU, non-emergency department, non-step down unit

Exclusion criteria

  • Children with a history of gestational age <28 weeks, chronic lung disease, complex or hemodynamically significant heart disease, immunodeficiency, or neuromuscular disease
  • Children being discharged with home oxygen therapy

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 56 centers
  • Children's of Alabama — Birmingham
  • Phoenix Children's Hospital - Arrowhead Campus — Glendale
  • Phoenix Children's Hospital — Phoenix
  • Adventist Health Lodi Memorial — Lodi
  • Children's Hospital Los Angeles — Los Angeles
  • Valley Children's Hospital — Madera
  • Children's Hospital Orange County (CHOC) — Orange
  • University of California Davis Children's Hospital — Sacramento
  • … and 48 more centers

Identifiers

NCT: NCT07243652 · BPS-2024C1-35425

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗